openPR Logo
Press release

TicketCreator 5.0: New Version Allows Printing of Copy Protected Tickets

06-07-2007 11:49 AM CET | IT, New Media & Software

Press release from: TicketCreator

The new version of the ticketing software TicketCreator makes it easier than ever to print tickets for events.

The new version of the ticketing software TicketCreator makes it easier than ever to print tickets for events.

Erlangen, June 5, 2007. Printing tickets has been a huge problem for many organizers of small- and medium-sized events, as tickets with row and seat numbers can only be printed with difficulties in normal word processing or graphics programs. This task is especially tedious for venues with varying numbers of seats per row or irregular row and seat numbers. Hence, many organizers print only unnumbered general admission tickets. Tickets without row and seat numbers, however, do not only look unprofessional but have also the disadvantage that the visitors have to be early to get good seats. This is very inconvenient for the customers, causes hustle and is for tickets of a certain price simply unacceptable. The organizer is additionally faced with the problem, that such tickets can be easily forged or copied, which reduces his revenues.

These problems are comfortably and comprehensively solved by the ticketing software TicketCreator (www.TicketCreator.com), which has been specifically developed for smaller organizations, such as choirs, orchestras, schools, and amateur theaters. Quickly set up new venues and print tickets with row and seat numbers. The seats can be easily assigned to different price categories, the ticket layout offers various options, and the ticket format can be freely chosen. And if the seats are not numbered yet TicketCreator can also print the respective seat labels.

A unique feature of TicketCreator 5.0 is the support of copy protected tickets. Tickets with serial numbers can be protect against forging and copying without additional costs for special paper or other security features. For this an encrypted barcode is printed on the ticket, which is checked at the entrance with a barcode scanner and the free software TicketCreator BarcodeChecker and allows only a single entry. This protects your revenues effectively without increasing the printing costs for the tickets.

TicketCreator does not require an expensive ticket printer or other additional hardware but prints tickets of any format on your normal printer. And checking copy-protected tickets requires only a simple barcode scanner (USB or P/S2).

Just test the free and fully functional evaluation copy of TicketCreator, which is available for download at www.TicketCreator.com, to convince yourself of the many features.

For further information, sample tickets, and video tutorials please visit our homepage at www.TicketCreator.com or the German page at www.TicketCreator.de.

Pricing and Availability
TicketCreator 5.0 runs under Win98, WinME, WinXP, and Windows Vista and starts at €149,- (about $200,-). Further information and the free evaluation copy is available from www.TicketCreator.com.

TicketCreator is a provider of ticketing software and based in Erlangen, Germany. For more information about TicketCreator visit www.TicketCreator.com or www.TicketCreator.de.

TicketCreator
Bohlenplatz 14
91054 Erlangen
Info@TicketCreator.de
www.TicketCreator.com or www.TicketCreator.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release TicketCreator 5.0: New Version Allows Printing of Copy Protected Tickets here

News-ID: 21829 • Views:

More Releases for Erlangen

03-17-2016 | Health & Medicine
PBirkel
Extracorporal Modified Immune Therapy (EMIT)
A tumor patient usually does not die from a benign tumor, but from a malignant tumor that maintains an uninhibited proliferation, which in turn interferes fatally with the vital functions of other organs. Apart from surgical procedures at an early stage, conventional cancer therapy is based on the philosophy that cancer cells should be destroyed with various destructive methods such as chemotherapy, radiation therapy, TKI, monoclonal antibodies, etc. All immunological research
03-15-2016 | Health & Medicine
PBirkel
An alternative cancer treatment: Extracorporal Modified Immune Therapy (EMIT)
EMIT is based on the special cultivation of somatic tumor cells and leucocytes of patients, it would be subject to such regulation, too. Due to such financial and administrative obstacles it is almost impossible to offer this promising treatment for public use.  If a physician acts against these regulations, this would be regarded as an indictable offence as mentioned above. Moreover, other problems emerge: Those who do not belong to academic
Cerbomed GmbH at the 11th European Congress on Epileptology in Stockholm
ERLANGEN/STOCKHOLM, 30.06.2014 – From June 30th until July 3rd 2014 the medical device company cerbomed GmbH from Erlangen, Germany, will present a further therapy option for people suffering from epilepsies at the 11th European Congress on Epileptology in Stockholm: The transcutaneous Vagus Nerve Stimulation (t-VNS) with the therapy device NEMOS. About t-VNS with NEMOS Transcutaneous Vagus Nerve Stimulation with NEMOS offers a further therapy option to epilepsy
Cerbomed GmbH at the 30th International Congress of Clinical Neurophysiology
ERLANGEN/BERLIN, 13.03.2014 – From March 19th until 23rd 2014 the medical device company cerbomed GmbH from Erlangen, Germany, will present the transcutaneous Vagus Nerve Stimulation (t-VNS) at the 30th International Congress of Clinical Neurophysiology. Please save March 21st and use the chance to get additional information about t-VNS at the Lunch Symposium “Transcutaneous Vagus Nerve Stimulation (t-VNS). Treatment option in epilepsy and pain.” from 12:15 to 13:45 p.m. About
Cerbomed GmbH at the 86th Congress of the German Society of Neurology
ERLANGEN/DRESDEN, Germany, September 12th, 2013 – At the 86th congress of the German Society of Neurology in Dresden the medical device company cerbomed GmbH, Erlangen, Germany, will present a further therapy option for patients suffering from hard-to-treat neurological and psychiatric illnesses: Between September 18th and 21st participants will get first-hand information about the transcutaneous Vagus Nerve Stimulation (t-VNS). About t-VNS The t-VNS offers a therapy option for patients suffering from epilepsies,
Cerbomed GmbH presents transcutaneous Vagus Nerve Stimulation at the 8th annual …
ERLANGEN/BERLIN, Germany, November 20th, 2012 – Between November 23rd and 24th, 2012 the medical device company cerbomed GmbH, Erlangen, Germany will present the transcutaneous Vagus Nerve Stimulation (t-VNS) at the 8th annual meeting of the German Society of Neuromodulation. Participants will get first-hand information about the new therapy option for patients suffering from difficult-to-treat epilepsies, depression and pain at the booth and in the course of a symposium on November